nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—Risedronate—osteoporosis	0.126	0.194	CbGbCtD
Naproxen—UGT1A1—Estradiol—osteoporosis	0.0659	0.102	CbGbCtD
Naproxen—ALB—Estropipate—osteoporosis	0.0602	0.0927	CbGbCtD
Naproxen—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0551	0.0849	CbGbCtD
Naproxen—SLCO1A2—Estradiol—osteoporosis	0.0484	0.0745	CbGbCtD
Naproxen—CYP1A2—Estropipate—osteoporosis	0.036	0.0555	CbGbCtD
Naproxen—SLC22A6—Conjugated Estrogens—osteoporosis	0.0334	0.0515	CbGbCtD
Naproxen—CYP2C9—Estropipate—osteoporosis	0.0324	0.05	CbGbCtD
Naproxen—CYP2C8—Raloxifene—osteoporosis	0.031	0.0478	CbGbCtD
Naproxen—CYP2C8—Ethinyl Estradiol—osteoporosis	0.03	0.0462	CbGbCtD
Naproxen—ALB—Estradiol—osteoporosis	0.025	0.0385	CbGbCtD
Naproxen—CYP2C8—Cholecalciferol—osteoporosis	0.024	0.0369	CbGbCtD
Naproxen—CYP2C8—Estradiol—osteoporosis	0.0193	0.0298	CbGbCtD
Naproxen—CYP1A2—Conjugated Estrogens—osteoporosis	0.017	0.0262	CbGbCtD
Naproxen—CYP2C9—Cholecalciferol—osteoporosis	0.0167	0.0258	CbGbCtD
Naproxen—CYP1A2—Estradiol—osteoporosis	0.0149	0.023	CbGbCtD
Naproxen—CYP2C9—Estradiol—osteoporosis	0.0135	0.0208	CbGbCtD
Naproxen—Convulsion—Conjugated Estrogens—osteoporosis	0.00011	0.000376	CcSEcCtD
Naproxen—Dry mouth—Zoledronate—osteoporosis	0.00011	0.000376	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000109	0.000376	CcSEcCtD
Naproxen—Fatigue—Ethinyl Estradiol—osteoporosis	0.000109	0.000375	CcSEcCtD
Naproxen—Pruritus—Alendronate—osteoporosis	0.000109	0.000374	CcSEcCtD
Naproxen—Dyspepsia—Risedronate—osteoporosis	0.000109	0.000373	CcSEcCtD
Naproxen—Eye disorder—Estradiol—osteoporosis	0.000109	0.000373	CcSEcCtD
Naproxen—Tinnitus—Estradiol—osteoporosis	0.000109	0.000372	CcSEcCtD
Naproxen—Constipation—Ethinyl Estradiol—osteoporosis	0.000108	0.000372	CcSEcCtD
Naproxen—Confusional state—Zoledronate—osteoporosis	0.000108	0.000371	CcSEcCtD
Naproxen—Hypersensitivity—Calcitriol—osteoporosis	0.000108	0.000371	CcSEcCtD
Naproxen—Cardiac disorder—Estradiol—osteoporosis	0.000108	0.000371	CcSEcCtD
Naproxen—Arthralgia—Conjugated Estrogens—osteoporosis	0.000108	0.00037	CcSEcCtD
Naproxen—Chest pain—Conjugated Estrogens—osteoporosis	0.000108	0.00037	CcSEcCtD
Naproxen—Myalgia—Conjugated Estrogens—osteoporosis	0.000108	0.00037	CcSEcCtD
Naproxen—Asthenia—Ibandronate—osteoporosis	0.000108	0.000369	CcSEcCtD
Naproxen—Anxiety—Conjugated Estrogens—osteoporosis	0.000107	0.000369	CcSEcCtD
Naproxen—Nausea—Etidronic acid—osteoporosis	0.000107	0.000368	CcSEcCtD
Naproxen—Oedema—Zoledronate—osteoporosis	0.000107	0.000368	CcSEcCtD
Naproxen—Anaphylactic shock—Zoledronate—osteoporosis	0.000107	0.000368	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000107	0.000367	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000107	0.000367	CcSEcCtD
Naproxen—Diarrhoea—Estropipate—osteoporosis	0.000107	0.000367	CcSEcCtD
Naproxen—Gastrointestinal disorder—Risedronate—osteoporosis	0.000107	0.000366	CcSEcCtD
Naproxen—Infection—Zoledronate—osteoporosis	0.000107	0.000366	CcSEcCtD
Naproxen—Fatigue—Risedronate—osteoporosis	0.000107	0.000366	CcSEcCtD
Naproxen—Insomnia—Pamidronate—osteoporosis	0.000106	0.000365	CcSEcCtD
Naproxen—Pruritus—Ibandronate—osteoporosis	0.000106	0.000364	CcSEcCtD
Naproxen—Constipation—Risedronate—osteoporosis	0.000106	0.000363	CcSEcCtD
Naproxen—Pain—Risedronate—osteoporosis	0.000106	0.000363	CcSEcCtD
Naproxen—Angiopathy—Estradiol—osteoporosis	0.000106	0.000362	CcSEcCtD
Naproxen—Shock—Zoledronate—osteoporosis	0.000106	0.000362	CcSEcCtD
Naproxen—Paraesthesia—Pamidronate—osteoporosis	0.000106	0.000362	CcSEcCtD
Naproxen—Diarrhoea—Alendronate—osteoporosis	0.000105	0.000362	CcSEcCtD
Naproxen—Asthenia—Calcitriol—osteoporosis	0.000105	0.000361	CcSEcCtD
Naproxen—Nervous system disorder—Zoledronate—osteoporosis	0.000105	0.000361	CcSEcCtD
Naproxen—Immune system disorder—Estradiol—osteoporosis	0.000105	0.000361	CcSEcCtD
Naproxen—Thrombocytopenia—Zoledronate—osteoporosis	0.000105	0.000361	CcSEcCtD
Naproxen—Mediastinal disorder—Estradiol—osteoporosis	0.000105	0.00036	CcSEcCtD
Naproxen—Dyspnoea—Pamidronate—osteoporosis	0.000105	0.000359	CcSEcCtD
Naproxen—Tachycardia—Zoledronate—osteoporosis	0.000105	0.000359	CcSEcCtD
Naproxen—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000104	0.000358	CcSEcCtD
Naproxen—Chills—Estradiol—osteoporosis	0.000104	0.000358	CcSEcCtD
Naproxen—Somnolence—Pamidronate—osteoporosis	0.000104	0.000358	CcSEcCtD
Naproxen—Skin disorder—Zoledronate—osteoporosis	0.000104	0.000358	CcSEcCtD
Naproxen—Pruritus—Calcitriol—osteoporosis	0.000104	0.000356	CcSEcCtD
Naproxen—Hyperhidrosis—Zoledronate—osteoporosis	0.000104	0.000356	CcSEcCtD
Naproxen—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000104	0.000356	CcSEcCtD
Naproxen—Diarrhoea—Raloxifene—osteoporosis	0.000104	0.000356	CcSEcCtD
Naproxen—Dyspepsia—Pamidronate—osteoporosis	0.000103	0.000355	CcSEcCtD
Naproxen—Dizziness—Estropipate—osteoporosis	0.000103	0.000355	CcSEcCtD
Naproxen—Oedema—Conjugated Estrogens—osteoporosis	0.000103	0.000355	CcSEcCtD
Naproxen—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000103	0.000355	CcSEcCtD
Naproxen—Alopecia—Estradiol—osteoporosis	0.000103	0.000353	CcSEcCtD
Naproxen—Infection—Conjugated Estrogens—osteoporosis	0.000103	0.000352	CcSEcCtD
Naproxen—Diarrhoea—Ibandronate—osteoporosis	0.000103	0.000352	CcSEcCtD
Naproxen—Anorexia—Zoledronate—osteoporosis	0.000102	0.000351	CcSEcCtD
Naproxen—Decreased appetite—Pamidronate—osteoporosis	0.000102	0.00035	CcSEcCtD
Naproxen—Mental disorder—Estradiol—osteoporosis	0.000102	0.00035	CcSEcCtD
Naproxen—Dizziness—Alendronate—osteoporosis	0.000102	0.00035	CcSEcCtD
Naproxen—Shock—Conjugated Estrogens—osteoporosis	0.000102	0.000349	CcSEcCtD
Naproxen—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000101	0.000348	CcSEcCtD
Naproxen—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000101	0.000348	CcSEcCtD
Naproxen—Malnutrition—Estradiol—osteoporosis	0.000101	0.000348	CcSEcCtD
Naproxen—Erythema—Estradiol—osteoporosis	0.000101	0.000348	CcSEcCtD
Naproxen—Fatigue—Pamidronate—osteoporosis	0.000101	0.000348	CcSEcCtD
Naproxen—Gastrointestinal pain—Risedronate—osteoporosis	0.000101	0.000347	CcSEcCtD
Naproxen—Tachycardia—Conjugated Estrogens—osteoporosis	0.000101	0.000346	CcSEcCtD
Naproxen—Urticaria—Ethinyl Estradiol—osteoporosis	0.000101	0.000346	CcSEcCtD
Naproxen—Pain—Pamidronate—osteoporosis	0.000101	0.000345	CcSEcCtD
Naproxen—Constipation—Pamidronate—osteoporosis	0.000101	0.000345	CcSEcCtD
Naproxen—Diarrhoea—Calcitriol—osteoporosis	0.0001	0.000345	CcSEcCtD
Naproxen—Skin disorder—Conjugated Estrogens—osteoporosis	0.0001	0.000344	CcSEcCtD
Naproxen—Hypotension—Zoledronate—osteoporosis	0.0001	0.000344	CcSEcCtD
Naproxen—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.0001	0.000344	CcSEcCtD
Naproxen—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.0001	0.000344	CcSEcCtD
Naproxen—Dizziness—Raloxifene—osteoporosis	0.0001	0.000344	CcSEcCtD
Naproxen—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.99e-05	0.000343	CcSEcCtD
Naproxen—Flatulence—Estradiol—osteoporosis	9.99e-05	0.000343	CcSEcCtD
Naproxen—Tension—Estradiol—osteoporosis	9.95e-05	0.000341	CcSEcCtD
Naproxen—Vomiting—Estropipate—osteoporosis	9.95e-05	0.000341	CcSEcCtD
Naproxen—Dizziness—Ibandronate—osteoporosis	9.92e-05	0.00034	CcSEcCtD
Naproxen—Rash—Estropipate—osteoporosis	9.86e-05	0.000338	CcSEcCtD
Naproxen—Dermatitis—Estropipate—osteoporosis	9.85e-05	0.000338	CcSEcCtD
Naproxen—Anorexia—Conjugated Estrogens—osteoporosis	9.85e-05	0.000338	CcSEcCtD
Naproxen—Nervousness—Estradiol—osteoporosis	9.85e-05	0.000338	CcSEcCtD
Naproxen—Urticaria—Risedronate—osteoporosis	9.82e-05	0.000337	CcSEcCtD
Naproxen—Headache—Estropipate—osteoporosis	9.8e-05	0.000336	CcSEcCtD
Naproxen—Vomiting—Alendronate—osteoporosis	9.8e-05	0.000336	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.78e-05	0.000336	CcSEcCtD
Naproxen—Abdominal pain—Risedronate—osteoporosis	9.77e-05	0.000335	CcSEcCtD
Naproxen—Body temperature increased—Risedronate—osteoporosis	9.77e-05	0.000335	CcSEcCtD
Naproxen—Muscle spasms—Estradiol—osteoporosis	9.75e-05	0.000334	CcSEcCtD
Naproxen—Rash—Alendronate—osteoporosis	9.72e-05	0.000333	CcSEcCtD
Naproxen—Insomnia—Zoledronate—osteoporosis	9.71e-05	0.000333	CcSEcCtD
Naproxen—Dermatitis—Alendronate—osteoporosis	9.71e-05	0.000333	CcSEcCtD
Naproxen—Feeling abnormal—Pamidronate—osteoporosis	9.69e-05	0.000332	CcSEcCtD
Naproxen—Hypotension—Conjugated Estrogens—osteoporosis	9.66e-05	0.000331	CcSEcCtD
Naproxen—Headache—Alendronate—osteoporosis	9.65e-05	0.000331	CcSEcCtD
Naproxen—Paraesthesia—Zoledronate—osteoporosis	9.64e-05	0.000331	CcSEcCtD
Naproxen—Vomiting—Raloxifene—osteoporosis	9.64e-05	0.000331	CcSEcCtD
Naproxen—Gastrointestinal pain—Pamidronate—osteoporosis	9.61e-05	0.00033	CcSEcCtD
Naproxen—Dyspnoea—Zoledronate—osteoporosis	9.57e-05	0.000328	CcSEcCtD
Naproxen—Rash—Raloxifene—osteoporosis	9.55e-05	0.000328	CcSEcCtD
Naproxen—Dermatitis—Raloxifene—osteoporosis	9.55e-05	0.000327	CcSEcCtD
Naproxen—Somnolence—Zoledronate—osteoporosis	9.54e-05	0.000327	CcSEcCtD
Naproxen—Vomiting—Ibandronate—osteoporosis	9.54e-05	0.000327	CcSEcCtD
Naproxen—Tremor—Estradiol—osteoporosis	9.5e-05	0.000326	CcSEcCtD
Naproxen—Headache—Raloxifene—osteoporosis	9.49e-05	0.000326	CcSEcCtD
Naproxen—Rash—Ibandronate—osteoporosis	9.46e-05	0.000324	CcSEcCtD
Naproxen—Dermatitis—Ibandronate—osteoporosis	9.45e-05	0.000324	CcSEcCtD
Naproxen—Dyspepsia—Zoledronate—osteoporosis	9.45e-05	0.000324	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	9.42e-05	0.000323	CcSEcCtD
Naproxen—Ill-defined disorder—Estradiol—osteoporosis	9.41e-05	0.000323	CcSEcCtD
Naproxen—Headache—Ibandronate—osteoporosis	9.4e-05	0.000322	CcSEcCtD
Naproxen—Insomnia—Conjugated Estrogens—osteoporosis	9.35e-05	0.000321	CcSEcCtD
Naproxen—Hypersensitivity—Ethinyl Estradiol—osteoporosis	9.34e-05	0.00032	CcSEcCtD
Naproxen—Vomiting—Calcitriol—osteoporosis	9.34e-05	0.00032	CcSEcCtD
Naproxen—Decreased appetite—Zoledronate—osteoporosis	9.33e-05	0.00032	CcSEcCtD
Naproxen—Nausea—Estropipate—osteoporosis	9.29e-05	0.000319	CcSEcCtD
Naproxen—Abdominal pain—Pamidronate—osteoporosis	9.29e-05	0.000319	CcSEcCtD
Naproxen—Body temperature increased—Pamidronate—osteoporosis	9.29e-05	0.000319	CcSEcCtD
Naproxen—Paraesthesia—Conjugated Estrogens—osteoporosis	9.28e-05	0.000318	CcSEcCtD
Naproxen—Gastrointestinal disorder—Zoledronate—osteoporosis	9.27e-05	0.000318	CcSEcCtD
Naproxen—Angioedema—Estradiol—osteoporosis	9.26e-05	0.000318	CcSEcCtD
Naproxen—Rash—Calcitriol—osteoporosis	9.26e-05	0.000318	CcSEcCtD
Naproxen—Fatigue—Zoledronate—osteoporosis	9.26e-05	0.000318	CcSEcCtD
Naproxen—Dermatitis—Calcitriol—osteoporosis	9.25e-05	0.000317	CcSEcCtD
Naproxen—Dyspnoea—Conjugated Estrogens—osteoporosis	9.22e-05	0.000316	CcSEcCtD
Naproxen—Headache—Calcitriol—osteoporosis	9.2e-05	0.000316	CcSEcCtD
Naproxen—Somnolence—Conjugated Estrogens—osteoporosis	9.19e-05	0.000315	CcSEcCtD
Naproxen—Constipation—Zoledronate—osteoporosis	9.18e-05	0.000315	CcSEcCtD
Naproxen—Pain—Zoledronate—osteoporosis	9.18e-05	0.000315	CcSEcCtD
Naproxen—Nausea—Alendronate—osteoporosis	9.15e-05	0.000314	CcSEcCtD
Naproxen—Malaise—Estradiol—osteoporosis	9.14e-05	0.000314	CcSEcCtD
Naproxen—Hypersensitivity—Risedronate—osteoporosis	9.11e-05	0.000312	CcSEcCtD
Naproxen—Vertigo—Estradiol—osteoporosis	9.11e-05	0.000312	CcSEcCtD
Naproxen—Dyspepsia—Conjugated Estrogens—osteoporosis	9.1e-05	0.000312	CcSEcCtD
Naproxen—Asthenia—Ethinyl Estradiol—osteoporosis	9.1e-05	0.000312	CcSEcCtD
Naproxen—Syncope—Estradiol—osteoporosis	9.09e-05	0.000312	CcSEcCtD
Naproxen—Nausea—Raloxifene—osteoporosis	9e-05	0.000309	CcSEcCtD
Naproxen—Decreased appetite—Conjugated Estrogens—osteoporosis	8.99e-05	0.000308	CcSEcCtD
Naproxen—Pruritus—Ethinyl Estradiol—osteoporosis	8.97e-05	0.000308	CcSEcCtD
Naproxen—Palpitations—Estradiol—osteoporosis	8.96e-05	0.000307	CcSEcCtD
Naproxen—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.92e-05	0.000306	CcSEcCtD
Naproxen—Fatigue—Conjugated Estrogens—osteoporosis	8.91e-05	0.000306	CcSEcCtD
Naproxen—Nausea—Ibandronate—osteoporosis	8.91e-05	0.000306	CcSEcCtD
Naproxen—Loss of consciousness—Estradiol—osteoporosis	8.91e-05	0.000306	CcSEcCtD
Naproxen—Asthenia—Risedronate—osteoporosis	8.87e-05	0.000304	CcSEcCtD
Naproxen—Feeling abnormal—Zoledronate—osteoporosis	8.85e-05	0.000303	CcSEcCtD
Naproxen—Cough—Estradiol—osteoporosis	8.85e-05	0.000303	CcSEcCtD
Naproxen—Pain—Conjugated Estrogens—osteoporosis	8.84e-05	0.000303	CcSEcCtD
Naproxen—Constipation—Conjugated Estrogens—osteoporosis	8.84e-05	0.000303	CcSEcCtD
Naproxen—Gastrointestinal pain—Zoledronate—osteoporosis	8.78e-05	0.000301	CcSEcCtD
Naproxen—Hypertension—Estradiol—osteoporosis	8.75e-05	0.0003	CcSEcCtD
Naproxen—Pruritus—Risedronate—osteoporosis	8.75e-05	0.0003	CcSEcCtD
Naproxen—Nausea—Calcitriol—osteoporosis	8.72e-05	0.000299	CcSEcCtD
Naproxen—Diarrhoea—Ethinyl Estradiol—osteoporosis	8.68e-05	0.000298	CcSEcCtD
Naproxen—Hypersensitivity—Pamidronate—osteoporosis	8.66e-05	0.000297	CcSEcCtD
Naproxen—Chest pain—Estradiol—osteoporosis	8.63e-05	0.000296	CcSEcCtD
Naproxen—Arthralgia—Estradiol—osteoporosis	8.63e-05	0.000296	CcSEcCtD
Naproxen—Myalgia—Estradiol—osteoporosis	8.63e-05	0.000296	CcSEcCtD
Naproxen—Anxiety—Estradiol—osteoporosis	8.6e-05	0.000295	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	8.57e-05	0.000294	CcSEcCtD
Naproxen—Urticaria—Zoledronate—osteoporosis	8.53e-05	0.000293	CcSEcCtD
Naproxen—Discomfort—Estradiol—osteoporosis	8.53e-05	0.000293	CcSEcCtD
Naproxen—Abdominal pain—Zoledronate—osteoporosis	8.49e-05	0.000291	CcSEcCtD
Naproxen—Body temperature increased—Zoledronate—osteoporosis	8.49e-05	0.000291	CcSEcCtD
Naproxen—Diarrhoea—Risedronate—osteoporosis	8.46e-05	0.00029	CcSEcCtD
Naproxen—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	8.45e-05	0.00029	CcSEcCtD
Naproxen—Dry mouth—Estradiol—osteoporosis	8.44e-05	0.00029	CcSEcCtD
Naproxen—Asthenia—Pamidronate—osteoporosis	8.43e-05	0.000289	CcSEcCtD
Naproxen—Dizziness—Ethinyl Estradiol—osteoporosis	8.39e-05	0.000288	CcSEcCtD
Naproxen—Confusional state—Estradiol—osteoporosis	8.34e-05	0.000286	CcSEcCtD
Naproxen—Pruritus—Pamidronate—osteoporosis	8.32e-05	0.000285	CcSEcCtD
Naproxen—Anaphylactic shock—Estradiol—osteoporosis	8.27e-05	0.000284	CcSEcCtD
Naproxen—Oedema—Estradiol—osteoporosis	8.27e-05	0.000284	CcSEcCtD
Naproxen—Infection—Estradiol—osteoporosis	8.22e-05	0.000282	CcSEcCtD
Naproxen—Urticaria—Conjugated Estrogens—osteoporosis	8.21e-05	0.000282	CcSEcCtD
Naproxen—Dizziness—Risedronate—osteoporosis	8.18e-05	0.00028	CcSEcCtD
Naproxen—Abdominal pain—Conjugated Estrogens—osteoporosis	8.17e-05	0.00028	CcSEcCtD
Naproxen—Body temperature increased—Conjugated Estrogens—osteoporosis	8.17e-05	0.00028	CcSEcCtD
Naproxen—Shock—Estradiol—osteoporosis	8.14e-05	0.000279	CcSEcCtD
Naproxen—Nervous system disorder—Estradiol—osteoporosis	8.11e-05	0.000278	CcSEcCtD
Naproxen—Tachycardia—Estradiol—osteoporosis	8.07e-05	0.000277	CcSEcCtD
Naproxen—Vomiting—Ethinyl Estradiol—osteoporosis	8.06e-05	0.000277	CcSEcCtD
Naproxen—Diarrhoea—Pamidronate—osteoporosis	8.04e-05	0.000276	CcSEcCtD
Naproxen—Skin disorder—Estradiol—osteoporosis	8.04e-05	0.000276	CcSEcCtD
Naproxen—Hyperhidrosis—Estradiol—osteoporosis	8e-05	0.000274	CcSEcCtD
Naproxen—Rash—Ethinyl Estradiol—osteoporosis	8e-05	0.000274	CcSEcCtD
Naproxen—Dermatitis—Ethinyl Estradiol—osteoporosis	7.99e-05	0.000274	CcSEcCtD
Naproxen—Headache—Ethinyl Estradiol—osteoporosis	7.94e-05	0.000273	CcSEcCtD
Naproxen—Hypersensitivity—Zoledronate—osteoporosis	7.91e-05	0.000271	CcSEcCtD
Naproxen—Vomiting—Risedronate—osteoporosis	7.86e-05	0.00027	CcSEcCtD
Naproxen—Rash—Risedronate—osteoporosis	7.8e-05	0.000267	CcSEcCtD
Naproxen—Dermatitis—Risedronate—osteoporosis	7.79e-05	0.000267	CcSEcCtD
Naproxen—Dizziness—Pamidronate—osteoporosis	7.77e-05	0.000267	CcSEcCtD
Naproxen—Headache—Risedronate—osteoporosis	7.75e-05	0.000266	CcSEcCtD
Naproxen—Asthenia—Zoledronate—osteoporosis	7.7e-05	0.000264	CcSEcCtD
Naproxen—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.62e-05	0.000261	CcSEcCtD
Naproxen—Pruritus—Zoledronate—osteoporosis	7.6e-05	0.000261	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Estradiol—osteoporosis	7.54e-05	0.000259	CcSEcCtD
Naproxen—Nausea—Ethinyl Estradiol—osteoporosis	7.53e-05	0.000258	CcSEcCtD
Naproxen—Insomnia—Estradiol—osteoporosis	7.48e-05	0.000257	CcSEcCtD
Naproxen—Vomiting—Pamidronate—osteoporosis	7.47e-05	0.000256	CcSEcCtD
Naproxen—Paraesthesia—Estradiol—osteoporosis	7.43e-05	0.000255	CcSEcCtD
Naproxen—Asthenia—Conjugated Estrogens—osteoporosis	7.42e-05	0.000254	CcSEcCtD
Naproxen—Rash—Pamidronate—osteoporosis	7.41e-05	0.000254	CcSEcCtD
Naproxen—Dermatitis—Pamidronate—osteoporosis	7.4e-05	0.000254	CcSEcCtD
Naproxen—Dyspnoea—Estradiol—osteoporosis	7.38e-05	0.000253	CcSEcCtD
Naproxen—Headache—Pamidronate—osteoporosis	7.36e-05	0.000253	CcSEcCtD
Naproxen—Somnolence—Estradiol—osteoporosis	7.35e-05	0.000252	CcSEcCtD
Naproxen—Diarrhoea—Zoledronate—osteoporosis	7.35e-05	0.000252	CcSEcCtD
Naproxen—Nausea—Risedronate—osteoporosis	7.34e-05	0.000252	CcSEcCtD
Naproxen—Pruritus—Conjugated Estrogens—osteoporosis	7.31e-05	0.000251	CcSEcCtD
Naproxen—Dyspepsia—Estradiol—osteoporosis	7.28e-05	0.00025	CcSEcCtD
Naproxen—Decreased appetite—Estradiol—osteoporosis	7.19e-05	0.000247	CcSEcCtD
Naproxen—Gastrointestinal disorder—Estradiol—osteoporosis	7.14e-05	0.000245	CcSEcCtD
Naproxen—Fatigue—Estradiol—osteoporosis	7.13e-05	0.000245	CcSEcCtD
Naproxen—Dizziness—Zoledronate—osteoporosis	7.1e-05	0.000244	CcSEcCtD
Naproxen—Pain—Estradiol—osteoporosis	7.07e-05	0.000243	CcSEcCtD
Naproxen—Constipation—Estradiol—osteoporosis	7.07e-05	0.000243	CcSEcCtD
Naproxen—Diarrhoea—Conjugated Estrogens—osteoporosis	7.07e-05	0.000243	CcSEcCtD
Naproxen—Nausea—Pamidronate—osteoporosis	6.98e-05	0.000239	CcSEcCtD
Naproxen—Dizziness—Conjugated Estrogens—osteoporosis	6.84e-05	0.000235	CcSEcCtD
Naproxen—Vomiting—Zoledronate—osteoporosis	6.83e-05	0.000234	CcSEcCtD
Naproxen—Feeling abnormal—Estradiol—osteoporosis	6.82e-05	0.000234	CcSEcCtD
Naproxen—Rash—Zoledronate—osteoporosis	6.77e-05	0.000232	CcSEcCtD
Naproxen—Gastrointestinal pain—Estradiol—osteoporosis	6.77e-05	0.000232	CcSEcCtD
Naproxen—Dermatitis—Zoledronate—osteoporosis	6.76e-05	0.000232	CcSEcCtD
Naproxen—Headache—Zoledronate—osteoporosis	6.73e-05	0.000231	CcSEcCtD
Naproxen—Vomiting—Conjugated Estrogens—osteoporosis	6.57e-05	0.000225	CcSEcCtD
Naproxen—Urticaria—Estradiol—osteoporosis	6.57e-05	0.000225	CcSEcCtD
Naproxen—Body temperature increased—Estradiol—osteoporosis	6.54e-05	0.000224	CcSEcCtD
Naproxen—Abdominal pain—Estradiol—osteoporosis	6.54e-05	0.000224	CcSEcCtD
Naproxen—Rash—Conjugated Estrogens—osteoporosis	6.52e-05	0.000224	CcSEcCtD
Naproxen—Dermatitis—Conjugated Estrogens—osteoporosis	6.51e-05	0.000223	CcSEcCtD
Naproxen—Headache—Conjugated Estrogens—osteoporosis	6.48e-05	0.000222	CcSEcCtD
Naproxen—Nausea—Zoledronate—osteoporosis	6.38e-05	0.000219	CcSEcCtD
Naproxen—Nausea—Conjugated Estrogens—osteoporosis	6.14e-05	0.000211	CcSEcCtD
Naproxen—Hypersensitivity—Estradiol—osteoporosis	6.1e-05	0.000209	CcSEcCtD
Naproxen—Asthenia—Estradiol—osteoporosis	5.94e-05	0.000204	CcSEcCtD
Naproxen—Pruritus—Estradiol—osteoporosis	5.85e-05	0.000201	CcSEcCtD
Naproxen—Diarrhoea—Estradiol—osteoporosis	5.66e-05	0.000194	CcSEcCtD
Naproxen—Dizziness—Estradiol—osteoporosis	5.47e-05	0.000188	CcSEcCtD
Naproxen—Vomiting—Estradiol—osteoporosis	5.26e-05	0.00018	CcSEcCtD
Naproxen—Rash—Estradiol—osteoporosis	5.22e-05	0.000179	CcSEcCtD
Naproxen—Dermatitis—Estradiol—osteoporosis	5.21e-05	0.000179	CcSEcCtD
Naproxen—Headache—Estradiol—osteoporosis	5.18e-05	0.000178	CcSEcCtD
Naproxen—Nausea—Estradiol—osteoporosis	4.91e-05	0.000169	CcSEcCtD
Naproxen—PTGS2—Disease—LRP5—osteoporosis	3.82e-05	0.000639	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MYC—osteoporosis	3.78e-05	0.000632	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	3.77e-05	0.000631	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.73e-05	0.000625	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—FDPS—osteoporosis	3.71e-05	0.000621	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PKM—osteoporosis	3.71e-05	0.000621	CbGpPWpGaD
Naproxen—ALB—Metabolism—PKM—osteoporosis	3.69e-05	0.000617	CbGpPWpGaD
Naproxen—ALB—Metabolism—FDPS—osteoporosis	3.69e-05	0.000617	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—P4HB—osteoporosis	3.69e-05	0.000617	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—TPI1—osteoporosis	3.66e-05	0.000613	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—osteoporosis	3.66e-05	0.000612	CbGpPWpGaD
Naproxen—PTGS2—Disease—LRP6—osteoporosis	3.65e-05	0.000611	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GAPDH—osteoporosis	3.62e-05	0.000606	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.6e-05	0.000603	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	3.59e-05	0.000601	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MTHFR—osteoporosis	3.57e-05	0.000598	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—RAP1A—osteoporosis	3.52e-05	0.00059	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—osteoporosis	3.52e-05	0.000589	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPD2—osteoporosis	3.52e-05	0.000589	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PGLS—osteoporosis	3.52e-05	0.000589	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—IDH2—osteoporosis	3.51e-05	0.000587	CbGpPWpGaD
Naproxen—PTGS2—Disease—RPL24—osteoporosis	3.51e-05	0.000587	CbGpPWpGaD
Naproxen—PTGS2—Disease—LTF—osteoporosis	3.51e-05	0.000587	CbGpPWpGaD
Naproxen—ALB—Hemostasis—FGB—osteoporosis	3.5e-05	0.000587	CbGpPWpGaD
Naproxen—ALB—Metabolism—PGLS—osteoporosis	3.5e-05	0.000585	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPD2—osteoporosis	3.5e-05	0.000585	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—KL—osteoporosis	3.47e-05	0.000581	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—P4HB—osteoporosis	3.44e-05	0.000576	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IRS2—osteoporosis	3.4e-05	0.000569	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GAPDH—osteoporosis	3.38e-05	0.000565	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—OXCT1—osteoporosis	3.36e-05	0.000563	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CA2—osteoporosis	3.36e-05	0.000563	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.33e-05	0.000557	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.31e-05	0.000554	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP27A1—osteoporosis	3.3e-05	0.000552	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—RAP1A—osteoporosis	3.29e-05	0.000551	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MGLL—osteoporosis	3.27e-05	0.000548	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ENO1—osteoporosis	3.27e-05	0.000548	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ADCY5—osteoporosis	3.25e-05	0.000544	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GPX1—osteoporosis	3.24e-05	0.000543	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PSMA2—osteoporosis	3.22e-05	0.00054	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PSMA5—osteoporosis	3.22e-05	0.00054	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PNP—osteoporosis	3.22e-05	0.000538	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ATIC—osteoporosis	3.22e-05	0.000538	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ACP5—osteoporosis	3.21e-05	0.000537	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—POMC—osteoporosis	3.2e-05	0.000536	CbGpPWpGaD
Naproxen—ALB—Metabolism—PNP—osteoporosis	3.2e-05	0.000535	CbGpPWpGaD
Naproxen—ALB—Metabolism—ATIC—osteoporosis	3.2e-05	0.000535	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.17e-05	0.00053	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.09e-05	0.000517	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.08e-05	0.000515	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.07e-05	0.000515	CbGpPWpGaD
Naproxen—PTGS2—Disease—ACP5—osteoporosis	3.04e-05	0.000509	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—FDPS—osteoporosis	3.02e-05	0.000505	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PKM—osteoporosis	3.02e-05	0.000505	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—MTHFR—osteoporosis	2.99e-05	0.000501	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TPI1—osteoporosis	2.98e-05	0.000499	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IRS1—osteoporosis	2.97e-05	0.000497	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.9e-05	0.000486	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PGLS—osteoporosis	2.86e-05	0.000479	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPD2—osteoporosis	2.86e-05	0.000479	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ENO1—osteoporosis	2.85e-05	0.000477	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—osteoporosis	2.84e-05	0.000475	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.83e-05	0.000474	CbGpPWpGaD
Naproxen—PTGS2—Disease—TPI1—osteoporosis	2.83e-05	0.000473	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PSMA2—osteoporosis	2.81e-05	0.00047	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PSMA5—osteoporosis	2.81e-05	0.00047	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—P4HB—osteoporosis	2.8e-05	0.00047	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6R—osteoporosis	2.79e-05	0.000466	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—IDH2—osteoporosis	2.78e-05	0.000466	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GAPDH—osteoporosis	2.75e-05	0.000461	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—POMC—osteoporosis	2.74e-05	0.000458	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CA2—osteoporosis	2.73e-05	0.000458	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—OXCT1—osteoporosis	2.73e-05	0.000458	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	2.72e-05	0.000455	CbGpPWpGaD
Naproxen—ALB—Metabolism—CA2—osteoporosis	2.72e-05	0.000455	CbGpPWpGaD
Naproxen—ALB—Metabolism—OXCT1—osteoporosis	2.72e-05	0.000455	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—RAP1A—osteoporosis	2.68e-05	0.000449	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MGLL—osteoporosis	2.66e-05	0.000446	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ENO1—osteoporosis	2.66e-05	0.000445	CbGpPWpGaD
Naproxen—PTGS2—Disease—P4HB—osteoporosis	2.66e-05	0.000445	CbGpPWpGaD
Naproxen—ALB—Metabolism—MGLL—osteoporosis	2.65e-05	0.000444	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SPP1—osteoporosis	2.63e-05	0.00044	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PSMA5—osteoporosis	2.62e-05	0.000439	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PSMA2—osteoporosis	2.62e-05	0.000439	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP27A1—osteoporosis	2.62e-05	0.000438	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PNP—osteoporosis	2.62e-05	0.000438	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ATIC—osteoporosis	2.62e-05	0.000438	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP19A1—osteoporosis	2.62e-05	0.000438	CbGpPWpGaD
Naproxen—PTGS2—Disease—GAPDH—osteoporosis	2.61e-05	0.000437	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PKM—osteoporosis	2.58e-05	0.000432	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—FDPS—osteoporosis	2.58e-05	0.000432	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.57e-05	0.00043	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.56e-05	0.000429	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ACP5—osteoporosis	2.55e-05	0.000426	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.51e-05	0.000421	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.51e-05	0.000421	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.5e-05	0.000418	CbGpPWpGaD
Naproxen—PTGS2—Disease—NFATC1—osteoporosis	2.48e-05	0.000415	CbGpPWpGaD
Naproxen—PTGS2—Disease—DKK1—osteoporosis	2.46e-05	0.000412	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PGLS—osteoporosis	2.45e-05	0.000409	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPD2—osteoporosis	2.45e-05	0.000409	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.39e-05	0.000401	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—POMC—osteoporosis	2.39e-05	0.0004	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IRS2—osteoporosis	2.38e-05	0.000398	CbGpPWpGaD
Naproxen—PTGS2—Disease—WNT1—osteoporosis	2.37e-05	0.000397	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TPI1—osteoporosis	2.37e-05	0.000396	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.34e-05	0.000391	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LEP—osteoporosis	2.33e-05	0.00039	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGA—osteoporosis	2.3e-05	0.000386	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP19A1—osteoporosis	2.28e-05	0.000381	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—IDH2—osteoporosis	2.27e-05	0.000379	CbGpPWpGaD
Naproxen—ALB—Metabolism—IDH2—osteoporosis	2.25e-05	0.000377	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ATIC—osteoporosis	2.24e-05	0.000374	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PNP—osteoporosis	2.24e-05	0.000374	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—P4HB—osteoporosis	2.23e-05	0.000373	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—OXCT1—osteoporosis	2.23e-05	0.000373	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CA2—osteoporosis	2.23e-05	0.000373	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ESR1—osteoporosis	2.22e-05	0.000372	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GAPDH—osteoporosis	2.19e-05	0.000366	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MGLL—osteoporosis	2.17e-05	0.000363	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ENO1—osteoporosis	2.17e-05	0.000363	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ADCY5—osteoporosis	2.14e-05	0.000358	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PSMA2—osteoporosis	2.14e-05	0.000358	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PSMA5—osteoporosis	2.14e-05	0.000358	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.000357	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GPX1—osteoporosis	2.13e-05	0.000357	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000356	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP19A1—osteoporosis	2.13e-05	0.000356	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP27A1—osteoporosis	2.12e-05	0.000355	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IRS1—osteoporosis	2.08e-05	0.000348	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ACP5—osteoporosis	2.07e-05	0.000347	CbGpPWpGaD
Naproxen—ALB—Metabolism—ACP5—osteoporosis	2.06e-05	0.000345	CbGpPWpGaD
Naproxen—PTGS2—Disease—ENO1—osteoporosis	2.05e-05	0.000344	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.05e-05	0.000343	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.05e-05	0.000342	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.03e-05	0.000341	CbGpPWpGaD
Naproxen—PTGS2—Disease—PSMA2—osteoporosis	2.02e-05	0.000339	CbGpPWpGaD
Naproxen—PTGS2—Disease—PSMA5—osteoporosis	2.02e-05	0.000339	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—POMC—osteoporosis	2e-05	0.000335	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MTHFR—osteoporosis	1.97e-05	0.000329	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6R—osteoporosis	1.95e-05	0.000327	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.94e-05	0.000325	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TPI1—osteoporosis	1.93e-05	0.000323	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF1—osteoporosis	1.92e-05	0.000322	CbGpPWpGaD
Naproxen—ALB—Metabolism—TPI1—osteoporosis	1.92e-05	0.000321	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—OXCT1—osteoporosis	1.9e-05	0.000318	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CA2—osteoporosis	1.9e-05	0.000318	CbGpPWpGaD
Naproxen—PTGS2—Disease—CALCA—osteoporosis	1.89e-05	0.000316	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ADCY5—osteoporosis	1.86e-05	0.000312	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.86e-05	0.000311	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GPX1—osteoporosis	1.85e-05	0.00031	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MGLL—osteoporosis	1.85e-05	0.00031	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.85e-05	0.000309	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—IDH2—osteoporosis	1.84e-05	0.000309	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—P4HB—osteoporosis	1.81e-05	0.000303	CbGpPWpGaD
Naproxen—ALB—Metabolism—P4HB—osteoporosis	1.8e-05	0.000302	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GAPDH—osteoporosis	1.78e-05	0.000298	CbGpPWpGaD
Naproxen—ALB—Metabolism—GAPDH—osteoporosis	1.77e-05	0.000296	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.75e-05	0.000293	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ADCY5—osteoporosis	1.74e-05	0.000291	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.00029	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP19A1—osteoporosis	1.73e-05	0.00029	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—RAP1A—osteoporosis	1.73e-05	0.00029	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GPX1—osteoporosis	1.73e-05	0.00029	CbGpPWpGaD
Naproxen—ALB—Metabolism—RAP1A—osteoporosis	1.72e-05	0.000288	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ENO1—osteoporosis	1.72e-05	0.000288	CbGpPWpGaD
Naproxen—PTGS2—Disease—KL—osteoporosis	1.71e-05	0.000287	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.71e-05	0.000287	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PSMA2—osteoporosis	1.7e-05	0.000284	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PSMA5—osteoporosis	1.7e-05	0.000284	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ACP5—osteoporosis	1.69e-05	0.000282	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.67e-05	0.000279	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MYC—osteoporosis	1.65e-05	0.000276	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFB1—osteoporosis	1.65e-05	0.000276	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—osteoporosis	1.6e-05	0.000267	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF1—osteoporosis	1.59e-05	0.000266	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—IDH2—osteoporosis	1.58e-05	0.000264	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—POMC—osteoporosis	1.57e-05	0.000263	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TPI1—osteoporosis	1.57e-05	0.000263	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.51e-05	0.000253	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.5e-05	0.000251	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.48e-05	0.000248	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—P4HB—osteoporosis	1.47e-05	0.000247	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GAPDH—osteoporosis	1.45e-05	0.000242	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ACP5—osteoporosis	1.44e-05	0.000241	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.42e-05	0.000238	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ADCY5—osteoporosis	1.42e-05	0.000237	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GPX1—osteoporosis	1.41e-05	0.000236	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000236	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ENO1—osteoporosis	1.4e-05	0.000234	CbGpPWpGaD
Naproxen—ALB—Metabolism—ENO1—osteoporosis	1.39e-05	0.000233	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000231	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000231	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP19A1—osteoporosis	1.38e-05	0.00023	CbGpPWpGaD
Naproxen—ALB—Metabolism—PSMA2—osteoporosis	1.37e-05	0.00023	CbGpPWpGaD
Naproxen—ALB—Metabolism—PSMA5—osteoporosis	1.37e-05	0.00023	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—POMC—osteoporosis	1.37e-05	0.000229	CbGpPWpGaD
Naproxen—PTGS2—Disease—ADCY5—osteoporosis	1.34e-05	0.000225	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TPI1—osteoporosis	1.34e-05	0.000224	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—osteoporosis	1.3e-05	0.000218	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—POMC—osteoporosis	1.28e-05	0.000214	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—P4HB—osteoporosis	1.26e-05	0.000211	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—osteoporosis	1.24e-05	0.000208	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000207	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—osteoporosis	1.23e-05	0.000207	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.23e-05	0.000206	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—RAP1A—osteoporosis	1.2e-05	0.000202	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS2—osteoporosis	1.17e-05	0.000197	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MYC—osteoporosis	1.16e-05	0.000194	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	1.15e-05	0.000193	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ENO1—osteoporosis	1.14e-05	0.000191	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ADCY5—osteoporosis	1.12e-05	0.000188	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000188	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000188	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—osteoporosis	1.12e-05	0.000187	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000187	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP19A1—osteoporosis	1.11e-05	0.000186	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.05e-05	0.000176	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—POMC—osteoporosis	1.04e-05	0.000174	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—osteoporosis	1.03e-05	0.000173	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS1—osteoporosis	1.02e-05	0.000172	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ENO1—osteoporosis	9.74e-06	0.000163	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6R—osteoporosis	9.63e-06	0.000161	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PSMA2—osteoporosis	9.59e-06	0.000161	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PSMA5—osteoporosis	9.59e-06	0.000161	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—osteoporosis	9.51e-06	0.000159	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ADCY5—osteoporosis	9.14e-06	0.000153	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—osteoporosis	9.11e-06	0.000153	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.11e-06	0.000152	CbGpPWpGaD
Naproxen—ALB—Metabolism—ADCY5—osteoporosis	9.09e-06	0.000152	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—osteoporosis	9.06e-06	0.000152	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—osteoporosis	8.69e-06	0.000146	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—osteoporosis	8.41e-06	0.000141	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—osteoporosis	8.36e-06	0.00014	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—POMC—osteoporosis	8.27e-06	0.000138	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.78e-06	0.00013	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADCY5—osteoporosis	7.44e-06	0.000125	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—osteoporosis	7.42e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—osteoporosis	6.84e-06	0.000115	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—POMC—osteoporosis	6.73e-06	0.000113	CbGpPWpGaD
Naproxen—ALB—Metabolism—POMC—osteoporosis	6.69e-06	0.000112	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADCY5—osteoporosis	6.36e-06	0.000106	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—osteoporosis	6.34e-06	0.000106	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—osteoporosis	5.85e-06	9.79e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MYC—osteoporosis	5.71e-06	9.55e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—osteoporosis	5.69e-06	9.53e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—POMC—osteoporosis	5.47e-06	9.16e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—POMC—osteoporosis	4.68e-06	7.83e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—osteoporosis	4.29e-06	7.18e-05	CbGpPWpGaD
